Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805737 · ClinicalTrials.gov registry record · NA
Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT03805737 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 43 participants.
The verdict
NCT03805737, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to understand better if indoor daylight Photo Dynamic Therapy (PDT) can provide effective lesion clearing versus conventional red lamp light therapy.
Interventions
- OTHER Amulez and sunlight
- OTHER Amulez and red light treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2021-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03805737
The ClinicalTrials.gov registry entry for NCT03805737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amulez and sunlight is the first listed.
NCT03805737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03805737 about?
NCT03805737 is a clinical study titled "Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis". The purpose of this study is to understand better if indoor daylight Photo Dynamic Therapy (PDT) can provide effective lesion clearing versus conventional red lamp light therapy.
What is the current status of trial NCT03805737?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2019-11-01. Estimated completion is 2021-10-06.
What interventions are being tested in trial NCT03805737?
The interventions under investigation include: Amulez and sunlight (OTHER), Amulez and red light treatment (OTHER).
Who is sponsoring clinical trial NCT03805737?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.